Cri-du-chat Syndrome Treatment Market By Treatment (Physiotherapy, Speech therapy, Occupational therapy), By End User (Hospitals and specialty clinics, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031

List of Tables

The global cri-du-chat syndrome treatment market was valued at $1,332.46 thousand in 2021, and is estimated to reach $1,918.21 thousand by 2031, growing at a CAGR of 3.7% from 2022 to 2031.

Cri du chat syndrome, also known as 5p- syndrome and cat cry syndrome, is a rare genetic disorder brought on by the deletion of genetic material from the short arm of chromosome 5 (the p arm), which is responsible for the illness. This unusual chromosomal loss has an unidentified cause. A high-pitched cry, a small head, and a flattened nasal bridge are the hallmarks of a baby with cri du chat syndrome.

It is estimated that one in every 50,000 or so infants has this disease. This estimate is decreasing. It may be as low as one in 25,000 with more sophisticated and regular genetic testing and many milder cases being detected. Thus, high prevalence of cri-du-chat syndrome along with increase in diagnosis for genetic diseases drives the market growth.

This syndrome has no particular pharmacological treatments available. To assist the child reach their full potential, children born with this genetic disorder will probably need ongoing care from a team made up of the parents, therapists, and medical and educational experts. They can achieve their full potential and lead fulfilling lives with early and consistent physical therapy, occupational and speech therapy. In addition, rise in awareness and advantages about physiotherapy, occupational & speech therapy is the major factor driving the market. The increase in prevalence of disease and out-of-pocket expenditure has led to a significant rise in healthcare cost. These factors propel the market growth.

However, high cost associated with therapy treatments are expected to hinder the growth of the market. Conversely, growth opportunities in emerging market to suffice the consumer demands is expected to provide a great opportunity for the investors to invest in the market.

The cri-du-chat syndrome treatment market is segmented on the basis of treatment, end user, and region. On the basis of product, the market is categorized into physiotherapy, speech therapy and occupation therapy. On the basis of end user, it is segmented into hospitals & specialty clinics and others. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and Latin America, the Middle East, and Africa (LAMEA).

The major players profiled in the report are Hoppers Physio, Jeevam Therapy, Physiocomestoyou, EURO-THERAPIES, Institute for Child Development, Blossoms Physiotherapy, Pediatric Advanced Therapy, Chatham Speech and Myo, Movement Masters Physical Therapy, and Rio Children's Hospital.

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the cri-du-chat syndrome treatment market analysis from 2021 to 2031 to identify the prevailing cri-du-chat syndrome treatment market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the cri-du-chat syndrome treatment market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global cri-du-chat syndrome treatment market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Treatment

Physiotherapy
Speech therapy
Occupational therapy

By End User

Hospitals and specialty clinics
Others

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- Hoppers Physio
- Chatham Speech and Myo
- Movement Masters Physical Therapy
- Rio Children's Hospital
- Blossoms Physiotherapy
- Institute for Child Development
- Pediatric Advanced Therapy
- EURO-THERAPIES
- Physiocomestoyou
- Jeevam Therapy

Product Code: A15445

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings
- 3.2.1.Top investment pockets
3.3.Porter's five forces analysis
3.4.Top player positioning
3.5.Market dynamics
- 3.5.1.Drivers
- 3.5.2.Restraints
- 3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market

CHAPTER 4: CRI-DU-CHAT SYNDROME TREATMENT MARKET, BY TREATMENT

4.1 Overview
- 4.1.1 Market size and forecast
4.2 Physiotherapy
- 4.2.1 Key market trends, growth factors and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market share analysis by country
4.3 Speech therapy
- 4.3.1 Key market trends, growth factors and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market share analysis by country
4.4 Occupational therapy
- 4.4.1 Key market trends, growth factors and opportunities
- 4.4.2 Market size and forecast, by region
- 4.4.3 Market share analysis by country

CHAPTER 5: CRI-DU-CHAT SYNDROME TREATMENT MARKET, BY END USER

5.1 Overview
- 5.1.1 Market size and forecast
5.2 Hospitals and specialty clinics
- 5.2.1 Key market trends, growth factors and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market share analysis by country
5.3 Others
- 5.3.1 Key market trends, growth factors and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market share analysis by country

CHAPTER 6: CRI-DU-CHAT SYNDROME TREATMENT MARKET, BY REGION

6.1 Overview
- 6.1.1 Market size and forecast
6.2 North America
- 6.2.1 Key trends and opportunities
- 6.2.2 North America Market size and forecast, by Treatment
- 6.2.3 North America Market size and forecast, by End User
- 6.2.4 North America Market size and forecast, by country
  - 6.2.4.1 U.S.
  - 6.2.4.1.1 Key market trends, growth factors and opportunities
  - 6.2.4.1.2 Market size and forecast, by Treatment
  - 6.2.4.1.3 Market size and forecast, by End User
  - 6.2.4.2 Canada
  - 6.2.4.2.1 Key market trends, growth factors and opportunities
  - 6.2.4.2.2 Market size and forecast, by Treatment
  - 6.2.4.2.3 Market size and forecast, by End User
  - 6.2.4.3 Mexico
  - 6.2.4.3.1 Key market trends, growth factors and opportunities
  - 6.2.4.3.2 Market size and forecast, by Treatment
  - 6.2.4.3.3 Market size and forecast, by End User
6.3 Europe
- 6.3.1 Key trends and opportunities
- 6.3.2 Europe Market size and forecast, by Treatment
- 6.3.3 Europe Market size and forecast, by End User
- 6.3.4 Europe Market size and forecast, by country
  - 6.3.4.1 Germany
  - 6.3.4.1.1 Key market trends, growth factors and opportunities
  - 6.3.4.1.2 Market size and forecast, by Treatment
  - 6.3.4.1.3 Market size and forecast, by End User
  - 6.3.4.2 France
  - 6.3.4.2.1 Key market trends, growth factors and opportunities
  - 6.3.4.2.2 Market size and forecast, by Treatment
  - 6.3.4.2.3 Market size and forecast, by End User
  - 6.3.4.3 UK
  - 6.3.4.3.1 Key market trends, growth factors and opportunities
  - 6.3.4.3.2 Market size and forecast, by Treatment
  - 6.3.4.3.3 Market size and forecast, by End User
  - 6.3.4.4 Italy
  - 6.3.4.4.1 Key market trends, growth factors and opportunities
  - 6.3.4.4.2 Market size and forecast, by Treatment
  - 6.3.4.4.3 Market size and forecast, by End User
  - 6.3.4.5 Spain
  - 6.3.4.5.1 Key market trends, growth factors and opportunities
  - 6.3.4.5.2 Market size and forecast, by Treatment
  - 6.3.4.5.3 Market size and forecast, by End User
  - 6.3.4.6 Rest of Europe
  - 6.3.4.6.1 Key market trends, growth factors and opportunities
  - 6.3.4.6.2 Market size and forecast, by Treatment
  - 6.3.4.6.3 Market size and forecast, by End User
6.4 Asia-Pacific
- 6.4.1 Key trends and opportunities
- 6.4.2 Asia-Pacific Market size and forecast, by Treatment
- 6.4.3 Asia-Pacific Market size and forecast, by End User
- 6.4.4 Asia-Pacific Market size and forecast, by country
  - 6.4.4.1 Japan
  - 6.4.4.1.1 Key market trends, growth factors and opportunities
  - 6.4.4.1.2 Market size and forecast, by Treatment
  - 6.4.4.1.3 Market size and forecast, by End User
  - 6.4.4.2 China
  - 6.4.4.2.1 Key market trends, growth factors and opportunities
  - 6.4.4.2.2 Market size and forecast, by Treatment
  - 6.4.4.2.3 Market size and forecast, by End User
  - 6.4.4.3 India
  - 6.4.4.3.1 Key market trends, growth factors and opportunities
  - 6.4.4.3.2 Market size and forecast, by Treatment
  - 6.4.4.3.3 Market size and forecast, by End User
  - 6.4.4.4 Australia
  - 6.4.4.4.1 Key market trends, growth factors and opportunities
  - 6.4.4.4.2 Market size and forecast, by Treatment
  - 6.4.4.4.3 Market size and forecast, by End User
  - 6.4.4.5 South Korea
  - 6.4.4.5.1 Key market trends, growth factors and opportunities
  - 6.4.4.5.2 Market size and forecast, by Treatment
  - 6.4.4.5.3 Market size and forecast, by End User
  - 6.4.4.6 Rest of Asia-Pacific
  - 6.4.4.6.1 Key market trends, growth factors and opportunities
  - 6.4.4.6.2 Market size and forecast, by Treatment
  - 6.4.4.6.3 Market size and forecast, by End User
6.5 LAMEA
- 6.5.1 Key trends and opportunities
- 6.5.2 LAMEA Market size and forecast, by Treatment
- 6.5.3 LAMEA Market size and forecast, by End User
- 6.5.4 LAMEA Market size and forecast, by country
  - 6.5.4.1 Brazil
  - 6.5.4.1.1 Key market trends, growth factors and opportunities
  - 6.5.4.1.2 Market size and forecast, by Treatment
  - 6.5.4.1.3 Market size and forecast, by End User
  - 6.5.4.2 Saudi Arabia
  - 6.5.4.2.1 Key market trends, growth factors and opportunities
  - 6.5.4.2.2 Market size and forecast, by Treatment
  - 6.5.4.2.3 Market size and forecast, by End User
  - 6.5.4.3 South Africa
  - 6.5.4.3.1 Key market trends, growth factors and opportunities
  - 6.5.4.3.2 Market size and forecast, by Treatment
  - 6.5.4.3.3 Market size and forecast, by End User
  - 6.5.4.4 Rest of LAMEA
  - 6.5.4.4.1 Key market trends, growth factors and opportunities
  - 6.5.4.4.2 Market size and forecast, by Treatment
  - 6.5.4.4.3 Market size and forecast, by End User

CHAPTER 7: COMPANY LANDSCAPE

7.1. Introduction
7.2. Top winning strategies
7.3. Product Mapping of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Key developments

CHAPTER 8: COMPANY PROFILES

8.1 Hoppers Physio
- 8.1.1 Company overview
- 8.1.2 Company snapshot
- 8.1.3 Operating business segments
- 8.1.4 Product portfolio
- 8.1.5 Business performance
- 8.1.6 Key strategic moves and developments
8.2 Jeevam Therapy
- 8.2.1 Company overview
- 8.2.2 Company snapshot
- 8.2.3 Operating business segments
- 8.2.4 Product portfolio
- 8.2.5 Business performance
- 8.2.6 Key strategic moves and developments
8.3 Physiocomestoyou
- 8.3.1 Company overview
- 8.3.2 Company snapshot
- 8.3.3 Operating business segments
- 8.3.4 Product portfolio
- 8.3.5 Business performance
- 8.3.6 Key strategic moves and developments
8.4 EURO-THERAPIES
- 8.4.1 Company overview
- 8.4.2 Company snapshot
- 8.4.3 Operating business segments
- 8.4.4 Product portfolio
- 8.4.5 Business performance
- 8.4.6 Key strategic moves and developments
8.5 Institute for Child Development
- 8.5.1 Company overview
- 8.5.2 Company snapshot
- 8.5.3 Operating business segments
- 8.5.4 Product portfolio
- 8.5.5 Business performance
- 8.5.6 Key strategic moves and developments
8.6 Blossoms Physiotherapy
- 8.6.1 Company overview
- 8.6.2 Company snapshot
- 8.6.3 Operating business segments
- 8.6.4 Product portfolio
- 8.6.5 Business performance
- 8.6.6 Key strategic moves and developments
8.7 Pediatric Advanced Therapy
- 8.7.1 Company overview
- 8.7.2 Company snapshot
- 8.7.3 Operating business segments
- 8.7.4 Product portfolio
- 8.7.5 Business performance
- 8.7.6 Key strategic moves and developments
8.8 Chatham Speech and Myo
- 8.8.1 Company overview
- 8.8.2 Company snapshot
- 8.8.3 Operating business segments
- 8.8.4 Product portfolio
- 8.8.5 Business performance
- 8.8.6 Key strategic moves and developments
8.9 Movement Masters Physical Therapy
- 8.9.1 Company overview
- 8.9.2 Company snapshot
- 8.9.3 Operating business segments
- 8.9.4 Product portfolio
- 8.9.5 Business performance
- 8.9.6 Key strategic moves and developments
8.10 Rio Children's Hospital
- 8.10.1 Company overview
- 8.10.2 Company snapshot
- 8.10.3 Operating business segments
- 8.10.4 Product portfolio
- 8.10.5 Business performance
- 8.10.6 Key strategic moves and developments